ADMA Biologics's 15min chart shows KDJ Death Cross, Bearish Marubozu.

ADMA Biologics's 15-minute chart has recently triggered a KDJ Death Cross, accompanied by a Bearish Marubozu formation on September 25th, 2025 at 12:30. This indicates a shift in momentum towards the downside, with potential for further price decreases. Sellers appear to be in control of the market, and it is likely that bearish momentum will persist.

ADMA Biologics, Inc. (NASDAQ: ADMA), a biopharmaceutical company, experienced a significant shift in momentum on September 25, 2025, at 12:30, as indicated by a KDJ Death Cross accompanied by a Bearish Marubozu formation on its 15-minute chart. This technical signal suggests a potential continuation of the downward trend, with sellers taking control of the market. The formation of these patterns, which are typically associated with bearish momentum, signals a potential for further price decreases.

According to Renaissance Investment Management's Q2 2025 "Small Cap Growth Strategy" investor letter, ADMA Biologics, Inc. (NASDAQ: ADMA) was highlighted as a potential investment, though the company's one-month return was -6.47%, and its shares lost 20.57% of their value over the last 52 weeks Renaissance Small Cap Growth Strategy Added ADMA Biologics (ADMA) to Its Portfolio in Q2^[1]. The company's total revenue for the second quarter of 2025 was $122 million, up 14% year-over-year. Despite its potential, the company is not among the 30 Most Popular Stocks Among Hedge Funds, with only 33 hedge fund portfolios holding the stock at the end of the second quarter Renaissance Small Cap Growth Strategy Added ADMA Biologics (ADMA) to Its Portfolio in Q2^[1].

The recent technical signals indicate a potential bearish trend for ADMA Biologics, Inc. (NASDAQ: ADMA). Investors should closely monitor the company's performance and the broader market conditions to make informed decisions. The KDJ Death Cross and Bearish Marubozu formation suggest that sellers are in control, and further price decreases are likely. However, it is essential to consider other factors, such as the company's fundamentals and the overall market sentiment, before making any investment decisions.